Literature DB >> 9306116

A new laparoscopic myomectomy technique for intramural fibroids penetrating the uterine cavity.

A Ostrzenski1.   

Abstract

OBJECTIVE: To evaluate laparoscopic removal of intramural leiomyomata uteri penetrating the uterine cavity, with compression of the uterine isthmic vessels, repair of the endometrial defect, and reconstruction of the myometrium in three layers. STUDY
DESIGN: 32 selected patients with penetrating intramural leiomyomata uteri were subjected to a new laparoscopic myomectomy technique. Conversion from laparoscopy to laparotomy, feasibility and safety of surgical technique, length of operation, hemoglobin loss, intra- and postoperative complications, and length of stay in hospital were evaluated.
RESULTS: All laparoscopic myomectomy attempts were completed laparoscopically without blood transfusion. The operative time ranged from 127 min to 246 min, (mean 163 min). The mean hemoglobin fall was 0.74 g/ml and no intraoperative nor postoperative complication was observed. The average postoperative hospital stay was 7.5 h.
CONCLUSION: This operation is safe, shows good reconstructive outcome, and offers an alternative approach to laparotomy, with all advantages of major surgery being executed through minimal access.

Entities:  

Mesh:

Year:  1997        PMID: 9306116     DOI: 10.1016/s0301-2115(97)02751-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  A systematic arrangement of laparoscopic total abdominal hysterectomy: a new technique.

Authors:  A Ostrzenski
Journal:  J Natl Med Assoc       Date:  1999-07       Impact factor: 1.798

2.  Laparoscopic myomectomy for large myomas.

Authors:  Hyo Jin Yoon; Min Sun Kyung; Un Suk Jung; Joong Sub Choi
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

3.  Laparoscopic myomectomy with lateral dissection of the uterine artery.

Authors:  Zdenek Holub; Antonin Jabor; Jan Lukac; Lev Kliment; Stepan Urbanek
Journal:  JSLS       Date:  2005 Oct-Dec       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.